USPTO serial 79163291
TWOCELLS
Reviewed by CopyMark Law Group
Reg. 5024404Status 709
- Filing date
- Status date
- Registration date
- Aug 23, 2016
- Examiner
- GILLES, DEBORAH LYNN MEINERS
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with TWOCELLS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Geoffrey D. Aurini
Geoffrey D. Aurini Harness, Dickey & Pierce, P.L.C.5445 Corporate DriveSuite 200Troy, MI 48098Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Cellular therapy products, namely, therapeutic cell strains for use in treatment of neurological and neuropsychiatric disorders, neuropathic pain and neurodegenerative disease | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 24, 2025 | Further Decision Processed by IB | — | |
| Mar 31, 2025 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Mar 31, 2025 | INNA | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| Mar 31, 2025 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Nov 3, 2023 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Mar 3, 2023 | C71T | CANCELLED SECTION 71 | — |
| Aug 23, 2021 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Mar 30, 2017 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Mar 24, 2017 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 11, 2017 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 11, 2017 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 23, 2016 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 22, 2016 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Aug 23, 2016 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 1, 2016 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jun 23, 2016 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 7, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 7, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 18, 2016 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 18, 2016 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| May 18, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 2, 2016 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 22, 2016 | ALIE | ASSIGNED TO LIE | — |
| Apr 7, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 31, 2016 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 31, 2016 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 31, 2016 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 31, 2016 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 28, 2015 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Dec 28, 2015 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 28, 2015 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 7, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 7, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 1, 2015 | ALIE | ASSIGNED TO LIE | — |
| Nov 13, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 11, 2015 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Jul 11, 2015 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 18, 2015 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 18, 2015 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 17, 2015 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 16, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 9, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 21, 2015 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 15, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 14, 2015 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Apr 9, 2015 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |